Plasma Amyloid And TAU As Dementia Biomarkers In Down Syndrome: Systematic Review And Meta-analyses.
….03) than DS individuals without dementia. Our results indicate that plasma Aβ40 levels may constitute a promising biomarker for predicting dementia status in individuals with DS. Further investigations using new ultra-sensitive assays are required to obtain…
read more